Ranjit Ray Selected Research

Ranjit Ray Research Topics

Disease

46	Infections 01/2022 - 03/2002
15	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 10/2003
9	Neoplasms (Cancer) 11/2021 - 11/2015
8	Fibrosis (Cirrhosis) 01/2019 - 03/2005
8	Vesicular Stomatitis 10/2011 - 04/2002
7	Liver Diseases (Liver Disease) 01/2019 - 06/2006
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 03/2005
5	Virus Diseases (Viral Diseases) 07/2014 - 07/2002
4	Hepatitis C 01/2020 - 03/2005
4	Persistent Infection 01/2014 - 03/2008
3	COVID-19 01/2022 - 12/2020
3	Inflammation (Inflammations) 01/2022 - 11/2013
3	Chronic Hepatitis C 01/2021 - 03/2005
3	Insulin Resistance 02/2014 - 03/2008
2	Liver Neoplasms (Liver Cancer) 01/2020 - 11/2017
2	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2017
2	Disease Progression 03/2015 - 06/2005
1	Vaccinia 01/2022
1	Alcoholic Fatty Liver 01/2021
1	Obesity 01/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2020
1	Viremia 01/2019
1	End Stage Liver Disease 03/2015

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2002
9	Glycoproteins (Glycoprotein)IBA 07/2013 - 03/2002
8	Neutralizing AntibodiesIBA 01/2022 - 03/2002
8	Antiviral Agents (Antivirals)IBA 01/2019 - 03/2005
7	Messenger RNA (mRNA)IBA 01/2022 - 05/2011
7	Complement System Proteins (Complement)IBA 01/2019 - 03/2002
7	InterferonsIBA 03/2015 - 03/2005
6	VaccinesIBA 01/2022 - 03/2008
6	CytokinesIBA 03/2021 - 05/2010
4	LigandsIBA 03/2021 - 03/2014
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2021 - 05/2006
4	RNA (Ribonucleic Acid)IBA 01/2020 - 10/2003
3	CCAAT-Enhancer-Binding ProteinsIBA 10/2021 - 07/2014
3	Transcription Factors (Transcription Factor)IBA 10/2021 - 03/2014
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019 - 01/2017
3	GelsolinIBA 04/2018 - 01/2012
3	MicroRNAs (MicroRNA)IBA 03/2015 - 01/2014
3	Poly I-CIBA 01/2014 - 11/2007
3	Viral ProteinsIBA 09/2012 - 06/2010
3	AntibodiesIBA 10/2011 - 03/2002
2	AntigensIBA 01/2022 - 04/2008
2	InflammasomesIBA 01/2022 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 03/2021 - 05/2010
2	ChemokinesIBA 03/2021 - 01/2017
2	Fibrinogen (Factor I)FDA Link 03/2021 - 05/2010
2	Cyclin D1IBA 01/2020 - 11/2017
2	CollagenIBA 01/2020 - 01/2017
2	Indicators and Reagents (Reagents)IBA 01/2019 - 04/2014
2	LipidsIBA 01/2019 - 04/2014
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 12/2017 - 01/2017
2	Conditioned Culture MediaIBA 12/2017 - 01/2016
2	Insulin Receptor Substrate ProteinsIBA 02/2014 - 03/2008
2	Insulin (Novolin)FDA Link 02/2014 - 06/2010
2	Apolipoproteins E (ApoE)IBA 10/2011 - 12/2003
2	Interferon-betaIBA 11/2010 - 11/2007
2	GlycosaminoglycansIBA 04/2007 - 05/2004
2	Ribavirin (Virazole)FDA LinkGeneric 01/2007 - 04/2006
1	Pharmaceutical PreparationsIBA 01/2022
1	Lipid NanoparticlesIBA 01/2022
1	NucleosidesIBA 01/2022
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 11/2021
1	capivasertibIBA 11/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2021
1	ChromatinIBA 10/2021
1	SARS-CoV-2 spike proteinIBA 10/2021
1	Long Noncoding RNAIBA 10/2021
1	TenascinIBA 03/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	SmokeIBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	AngiotensinsIBA 12/2020
1	GlypicansIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	CateninsIBA 01/2020
1	Human Serum Albumin FDA LinkGeneric 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	Ataxia Telangiectasia Mutated ProteinsIBA 01/2020
1	Alkaline PhosphataseIBA 01/2019
1	Rheumatoid FactorIBA 01/2019
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2019
1	AlbuminsIBA 01/2019
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2017
1	EndoglinIBA 11/2017
1	InterleukinsIBA 01/2017
1	Cysteine (L-Cysteine)FDA Link 01/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2016
1	Complement C3-C5 Convertases (C3 Convertase)IBA 01/2016
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 11/2015
1	ErbB Receptors (EGF Receptor)IBA 03/2015
1	Epidermal Growth Factor (EGF)IBA 03/2015
1	Claudin-1IBA 03/2015
1	Biomarkers (Surrogate Marker)IBA 03/2015

Therapy/Procedure

9	Therapeutics 01/2022 - 04/2006
2	Liver Transplantation 03/2015 - 02/2014
1	Intraperitoneal Injections 01/2021
1	Aftercare (After-Treatment) 01/2019